Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO WCGIC 2020 | Localized anal cancer in patients with HIV

Rachel Riechelmann • 6 Jul 2020
ESMO WCGIC 2020
Gastrointestinal Cancer Rectal Cancer Cisplatin Mitomycin

Rachel Riechelmann, MD, PhD, of the AC Camargo Cancer Canter, São Paulo, Brazil, discusses a retrospective multicenter study evaluating the outcomes of localized anal cancer in patients with HIV infection, and the implications this has on salvage surgeries for this indication. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

More from Rachel Riechelmann

3:31
Incidence of germline variants in young adults with NETs
Rachel Riechelmann • 6 Jul 2020
1:43
GASTHER2: trastuzumab for advanced gastric cancer
Rachel Riechelmann • 6 Jul 2020
1:58
Gemcitabine-based chemotherapy after FOLFIRINOX in advanced pancreatic cancer
Rachel Riechelmann • 6 Jul 2020

Related Videos

0:52
DRP-104 with durvalumab in fibrolamellar hepatocellular carcinoma
Marina Baretti • 9 Apr 2024
1:06
The emerging role of cancer vaccines in treating liver cancer
Marina Baretti • 9 Apr 2024
1:33
Peptide vaccines with ICIs for fibrolamellar hepatocellular carcinoma
Marina Baretti • 9 Apr 2024
4:12
PETRA: saruparib in solid tumors with BRCA1/2, PALB2 or RAD51C/D mutations
Timothy Yap • 7 Apr 2024
The content of VJOncology is intended for healthcare professionals